MOBERG DERMA CLOSED TRANCHE 2 OF FINANCING

The pharmaceutical company Moberg Derma completed the second tranche of its share issue according to plan. During 2009, a total of SEK 40 million has been secured. The second tranche of SEK 10 million was directed primarily to existing shareholders. More than SEK 110 million has been raised since the company was established in March 2006. “We are very pleased with the strong support from our investors. Through the new share issue financing has been secured for continued development of the product portfolio as well as initial commercialization activities,” says Peter Wolpert, President and CEO of Moberg Derma.

Tags: